Product NDC: | 42291-320 |
Proprietary Name: | Hydroxychloroquine Sulfate |
Non Proprietary Name: | Hydroxychloroquine Sulfate |
Active Ingredient(s): | 200 mg/1 & nbsp; Hydroxychloroquine Sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42291-320 |
Labeler Name: | AvKARE, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040133 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120229 |
Package NDC: | 42291-320-18 |
Package Description: | 180 TABLET in 1 BOTTLE (42291-320-18) |
NDC Code | 42291-320-18 |
Proprietary Name | Hydroxychloroquine Sulfate |
Package Description | 180 TABLET in 1 BOTTLE (42291-320-18) |
Product NDC | 42291-320 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydroxychloroquine Sulfate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120229 |
Marketing Category Name | ANDA |
Labeler Name | AvKARE, Inc. |
Substance Name | HYDROXYCHLOROQUINE SULFATE |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antirheumatic Agent [EPC] |